Paul Reider - 01 Apr 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Commercial Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Paul Reider
Issuer symbol
CHRS
Transactions as of
01 Apr 2023
Net transactions value
-$16,765
Form type
4
Filing time
04 Apr 2023, 20:57:52 UTC
Previous filing
28 Mar 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $16,765 -2,451 -2.7% $6.84 87,053 01 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.